CliffBio
biologic

Strensiq

asfotase alfa

Loss of exclusivity—loss of exclusivity
CompanyAlexion Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameStrensiq
Active ingredientasfotase alfa
Strength18MG/0.45ML
Dosage formInjection
RouteSubcutaneous
ModalityBiologic
Marketing statusRx

More from Alexion Pharmaceuticals

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.